Skip to content

Clinical application of interventional devascularization embolization and ablation (idea) for hemorrhoids

Clinical application of interventional devascularization embolization and ablation (idea) for hemorrhoids

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037637
Enrollment
Unknown
Registered
2020-08-29
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemorrhoids

Interventions

Experimental group:Interventional embolization
control group:ligation of intirnal hemorrhoid

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Grade III internal hemorrhoids; or mixed hemorrhoids mainly composed of internal hemorrhoids (internal hemorrhoids are classified as grade III). (2) According to the indications of operation, the patients received surgical treatment for the first time. (3) There was no contraindication. (4) Patients aged between 18 and 65 years old, male and female, complete informed consent and relevant notification. (5) Good compliance. (6) Those who have signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients who have previously received sclerotherapy. (2) Hemorrhoids with acute incarceration or thrombosis or complicated with anal fistula and anal fissure. (3) Patients with perianal skin diseases. (4) Pregnant or lactating women;. (5) Patients with obvious defecation disorder. (6) Patients with liver cirrhosis complicated with portal hypertension, ulcerative colitis, colon cancer, rectal cancer, colon polyps, tuberculosis, hepatitis and other infectious diseases, coronary heart disease, hypertension and other cardiovascular diseases, diabetes and other endocrine and metabolic diseases. (7) Patients who have received other clinical trials within 6 months before the start of the trial. (8) Patients who could not cooperate with the completion of the study plan, including language difficulties, infectious diseases and other medical history.

Design outcomes

Primary

MeasureTime frame
Recovery of life;

Secondary

MeasureTime frame
recurrence;Hemodynamic changes of hemorrhoid artery;complications;

Countries

China

Contacts

Public ContactLuo Chunsheng

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

719641498@qq.com+86 21-20256187

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026